Autopsy report · NCT06895681

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

“IRB study closure”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

University of California, San Francisco

Sponsor type

University, hospital or other

Conditions

Solid Tumor; Solid Tumor, Adult; Somatic Mutation; Solid Tumor, Unspecified, Adult; Hereditary Cancer

Interventions

Blood Sample; Tissue Sample; Excess fluid Sample; Medical Chart Review

Participants

0

Trials that died the same way

• Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder
  “IRB Closure” (81% match in meaning)
• A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients
  “Merged IRB study created” (75% match in meaning)
• Methadone as an Alternative Treatment for Children Underdoing HSCT
  “Study is closed with the IRB due to no funding. May resume once funding is obtained.” (74% match in meaning)
• A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer
  “The IRB which was overseeing the study stopped overseeing it” (73% match in meaning)
• ACB + IPACK Block With or Without Local Infiltration in RA-TKA
  “The P.I. decided to cancel this study. On 10/08/19, a study closure request was submitted to the IRB.” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.